Legal Notice

Use of this website and its contents is governed by the terms and conditions set out below. AstraZeneca Limited (AstraZeneca) reserves its rights to update these terms and conditions from time to time without notice.

Disclaimer
AstraZeneca has taken every reasonable effort to provide current and accurate information on this site. However, users of the site are advised that, to the extent permitted by law, no liability is assumed by AstraZeneca for any losses suffered directly or indirectly by any person relying on the information contained on this website. All users of the site use and access it and its contents at their own risk.
The product information available on this site is not medical advice. All questions regarding particular medical issues should be directed to a health care professional.

External Links
A number of external links have been included for additional information. AstraZeneca does not accept any responsibility for the content or operation of any external site linked to or referenced from this site. A link to a website is provided for convenience only and is not, and should not, be taken as endorsement of the linked site by AstraZeneca. AstraZeneca does not necessarily endorse any site that has a link to this website.

Intellectual Property
All content on this website, including (but not limited to) text and images are owned, licensed or controlled by AstraZeneca. The trademarks used on this website are owned by their proprietors as noted. Unauthorised reproduction of AstraZeneca’s content on this website is strictly forbidden. You may download or print extracts of website material for personal and non-commercial use only. Reproduction of website content for commercial purposes requires written authorisation from AstraZeneca.

Privacy Policy
AstraZeneca acknowledges its obligations under the Privacy Act 1993 and the Health Information Privacy Code 1994. AstraZeneca collects some standard technical information regarding visitors to this website, which will only be used in nonpersonally identifiable form for maintaining and operating this website and statistical purposes.

Governing Law
This website has been produced to provide information within New Zealand only. These terms and conditions shall governed by and interpreted in accordance with of the laws of New Zealand. The illegality, invalidity, or unenforceability of any term or condition contained herein under the law of any relevant jurisdiction will not affect the legality, validity, or enforceability of that provision under any other law, or the legality, validity or enforceability of any other term or condition in this notice.

Contact Us
If you have any questions about these terms and conditions, please contact us at:

AstraZeneca Limited
Level 5, 15 Hopetoun St
Freemans Bay
Auckland 1011
Telephone: (09) 306 5650
Fax: (09) 306 5651

The information on this website does not replace the individual advice and consultation of a doctor. Check with your doctor to see if Crestor is right for you.

Legal Notice

CRESTOR is indicated for patients with no history of cardiovascular events (such as stroke or heart attack), but with at least two conventional risk factors. References: 1. Jones P, et al. Am J Cardiol 2003;92:152-160. 2. Wolffenbuttel B, et al. J Int Med 2005;257:531-539. 3. Olsson AG, et al. AM Heart J 2002;144:1044-1051. 4. Clearfield M, et al. Trials 2006;7:35. 5. Schuster H, et al. Am Heart J 2004;147:705-712. 6. Baigent C, et al. Lancet 2005;366:1267-1278. 7. Schwartz G, et al. Am Heart J 2004;148:e4. 8. Berne C, et al. Cardiovasc Diabetol 2005:4(1):7. 9. Paoletti R, et al. J Cardiovasc Risk 2001;8:383-390. 10. Brown W, et al. Am Heart J 2002;144:1036-1043. 11. CRESTOR Datasheet. 9 July 2009. 12. Data on file, AstraZeneca. 13. Ridker, P M et al NEJM 359 (21):2195-2207.

CRESTOR contains rosuvastatin in 5mg, 10mg, 20mg and 40mg tablets. Uses CRESTOR lowers "bad" LDL cholesterol and raises "good" HDL cholesterol. Do not use if you are allergic to rosuvastatin, you are pregnant, breast feeding or have active liver disease. Cautions Allergies to other statins, liver problems, kidney problems, unexplained muscle pain, regular excess alcohol consumption.
Side Effects Most people taking CRESTOR do not suffer any unwanted effects. Effects that have been experienced include: headache, constipation, dizziness, nausea, stomach pain, unusual tiredness, skin rash, itching or hives. Rare side effects reported: muscle pain and swelling to the face, eyelids and lips. Medicine Classification Prescription Medicine use strictly as directed. If symptoms continue or you experience side effects, see your doctor, pharmacist or health professional. Consult your doctor to see if CRESTOR is right for you. CRESTOR is an unfunded medicine. Your doctors fee and prescription fee will also apply. For full consumer information please refer to the manufacturer's Consumer Medicine Information Sheet available at www.medsafe.govt.nz. 17 March 2008. Trademarks herein are property of the AstraZeneca group. AstraZeneca Limited, Private Bag 92175/299, Auckland 1142. Telephone (09) 306 5650 or Facsimile (09) 306 5651. TAPS CH2961. MAY 2011. BCG2-H CRE2074.

Last updated: May 2011.